drugset / Trial / NCT02722044
Usability of an AI for M923 in Subjects With Moderate to Severe RA
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the usability of an auto-injector (AI) for the delivery of M923 in patients with rheumatoid arthritis (RA)
Timeline
- Start
- 2016-04
- Primary completion
- 2017-02-21
- Completion
- 2017-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | M923 | Monoclonal antibody | — | Subcutaneous |